SCIESCOPUSQ2
EXPERT OPINION ON PHARMACOTHERAPY
TAYLOR & FRANCIS LTD, United Kingdom
EXPERT OPINION ON PHARMACOTHERAPY is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1465-6566, eISSN 1744-7666. Indexed in SCIE, SCOPUS. Metrics: JIF 2.7, CiteScore 4.6, SJR 0.672, SNIP 0.68. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 6,290 papers from this journal.
CiteScore
4.60
Scopus citation metric
SJR
0.672
SCImago rank
SNIP
0.68
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1465-6566
- eISSN
- 1744-7666
- Abbreviation
- EXPERT OPIN PHARMACO
- Publisher
- TAYLOR & FRANCIS LTD
- Country
- United Kingdom
Web of Science categories
SCIEPHARMACOLOGY & PHARMACY
Scopus ASJC categories
2736 Pharmacology (medical)3004 Pharmacology
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- The latest pharmacotherapeutic options for the treatment of IgA nephropathy in the pediatric population
2026
- Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction
2026
- Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases.
2026 · 1 citations
- Role of novel β-lactam antibiotics in the treatment of bacterial pneumonia
2026
- Targeted therapies in thoracic neuroendocrine tumors: challenges and failures of tyrosine kinase inhibition in lung and thymic carcinoids.
2026
Most cited papers
- Albumin-bound paclitaxel: a next-generation taxane
2006 · 655 citations
- Toxicity of platinum compounds
2003 · 572 citations
- Paclitaxel in cancer therapy
2002 · 347 citations
- Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control
2004 · 338 citations
- Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
2014 · 315 citations